Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02382783 · ClinicalTrials.gov registry record · NA

Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
178
Enrollment target

NCT02382783: Completed NA study, sponsored by Mayo Clinic.

NCT02382783 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02382783, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target

Study Summary

The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).

Interventions

  • OTHER FLARE Intervention Group

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2015-03
Est. Completion 2020-07-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT02382783

The ClinicalTrials.gov registry entry for NCT02382783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FLARE Intervention Group is the first listed.

NCT02382783 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02382783 about?

NCT02382783 is a clinical study titled "Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)". The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).

What is the current status of trial NCT02382783?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2015-03. Estimated completion is 2020-07-01.

What interventions are being tested in trial NCT02382783?

The interventions under investigation include: FLARE Intervention Group (OTHER).

Who is sponsoring clinical trial NCT02382783?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.